株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の末梢血管向けデバイス市場:製品タイプ・地域別 - 成長、動向、予測

Peripheral Vascular Devices Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 390901
出版日 ページ情報 英文 115 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
世界の末梢血管向けデバイス市場:製品タイプ・地域別 - 成長、動向、予測 Peripheral Vascular Devices Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年03月01日 ページ情報: 英文 115 Pages
概要

世界の末梢血管向けデバイス市場は、2018年から2023年の調査期間に7.1%のCAGRで推移することが予測されています。地域別では、心血管疾患の罹患率の上昇が見られ、大手参入企業を擁する北米が最大市場として台頭しています。

当レポートでは、末梢血管向けデバイスの世界市場について調査し、市場の概要、製品タイプ・地域別の市場動向、市場規模の推移と予測、市場シェア、市場促進・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ポーターのファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 成長要因、阻害要因、市場機会、課題の分析(DROC)

  • 市場の成長要因
    • 末梢血管動脈疾患の増加による低侵襲手術の需要増加
    • 末梢動脈疾患の罹患率の上昇
    • ライフスタイルの変化と高齢者人口の増加
    • 技術発展による末梢血管向けデバイスの応用範囲の拡大
  • 市場の阻害要因
    • 厳格な規制に起因する製品承認の遅れ
    • 末梢血管用デバイスの適切な償還制度の欠如
    • 市場の高度な断片化がもたらす価格破壊
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • 製品タイプ別
    • 末梢血管ステント
    • 末梢血管拡張術(PTA)用バルーンカテーテル
    • 末梢血管拡張術(PTA)用ガイドワイヤー
    • アテローム切除装置
    • 慢性完全閉塞病変(CTO)用デバイス
    • 大動脈ステント
    • 外科用合成グラフト
    • 塞栓予防装置
    • 下大静脈(IVC)フィルター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • 合併・買収分析
  • 合意、コラボレーション、パートナーシップ
  • 新製品の発売

第9章 主要企業

  • Abbott Vascular
  • The Boston Scientific Corporation
  • CRBard, Inc.
  • Cook Group
  • Cordis Corporation
  • Covidien PLC
  • Edward Lifesciences
  • Medtronic
  • St. Jude Medical
  • Volcano Corporation

第10章 市場の将来展望

目次
Product Code: 54386

Market Overview

Peripheral arterial disease (PAD) is caused by a narrowing or blocking of the blood vessels due to a plaque build-up. This condition can lead to tissue death, heart stroke, aneurysms, or kidney diseases, if left untreated. According to the National Institute of Health, one in every 20 American, who is over the age of 50, has PAD. It has been affecting eight to 12 million people in the United States, especially those over 50 years. As the population is growing, the prevalence of the disease is increasing, which could grow from 9.6 million to reach 19 million overall, globally by 2050. With the aging of the global population, it seems likely that PAD will be increasingly common in the future. Hence, the statistics show that the number of PAD is increasing at a faster pace, which is ultimately driving the market of peripheral arterial disease. Other factors, such as the rising demand for minimally-invasive procedures, especially for peripheral arterial disease, lifestyle changes, increase in aging population, and technological advancements have broadened the range of the peripheral vascular devices.

Scope of the Report

Vascular devices can be referred to as a medical device utilized in the case of catheterization post a cardiovascular surgery for the closure and achieving hemostasis in the artery.

Key Market Trends

Atherectomy Devices are expected to dominate the overall market

The market on the basis of device type is segmented into peripheral vascular stents, peripheral transluminal angioplasty (PTA) balloon catheters, peripheral transluminal angioplasty (PTA) guidewires, atherectomy devices, chronic total occlusion (CTO) devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters. The atherectomy devices segment is expected to dominate the overall market, owing to the increasing prevalence of atherosclerosis, rising obesity, lifestyle-related disorders, and hence, the growing adoption.

North America dominates the peripheral vascular devices market

North America dominated the peripheral vascular devices market in 2018 and is expected to grow in the future due to factors, such as the rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in the region. Europe holds the second largest position in the market, which is followed by the APAC region.

Competitive Landscape

The presence of the major market players, such as Abbott, Boston Scientific Corporation, Becton Dickinson and Company, Cook Group, Medtronic, and others is intensifying the market competition. The increasing innovation and rise in investment for various public and private organizations are expected to intensify the industry rivalry across the globe.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Minimally-Invasive Procedures, Especially for Peripheral Arterial Disease
    • 4.2.2 Increase in incidence of Peripheral Arterial Disease (PAD)
    • 4.2.3 Lifestyle Changes and Increase in Ageing Population
    • 4.2.4 Technological Advancements have broadened the Range of Peripheral Vascular Devices
  • 4.3 Market Restraints
    • 4.3.1 Delay in Marketing Approval for Peripheral Vascular Devices due to Stringent Regulations
    • 4.3.2 Lack of Proper Reimbursement Policies for Peripheral Vascular Devices
    • 4.3.3 Highly-Fragmented Market Leading To Peripheral Vascular Devices Price Erosion
  • 4.4 Porters Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Peripheral Vascular Stents
    • 5.1.2 Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
    • 5.1.3 Peripheral Transluminal Angioplasty (PTA) Guidewires
    • 5.1.4 Atherectomy Devices
    • 5.1.5 Chronic Total Occlusion (CTO) Devices
    • 5.1.6 Aortic Stents
    • 5.1.7 Synthetic Surgical Grafts
    • 5.1.8 Embolic Protection Devices
    • 5.1.9 Inferior Vena Cava Filters
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 US
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 UK
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East & Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East & Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Cook Group
    • 6.1.5 Cordis Corporation
    • 6.1.6 Edward Lifesciences
    • 6.1.7 Medtronic PLC
    • 6.1.8 Volcano Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top